Incidence of primary toxoplasma infections during pregnancy in southern Finland: A prospective cohort study

Scandinavian Journal of Infectious Diseases

Volumn 24, Issue 1, 1992, Pages 97-104

  Lappalainen, Maija ^a   Koskela, Pentti ^b   Hedman, Klaus ^a   Teramo, Kari ^a   Ämmala, Pirkko ^a   Hiilesmaa, Vilho ^a   Koskiniemi, Marjaleena ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FANSIDAR; SPIRAMYCIN;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CONGENITAL TOXOPLASMOSIS; ERYTHEMA; FEMALE; FETUS OUTCOME; FINLAND; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; PREGNANCY; PRIMARY INFECTION; PRIORITY JOURNAL; SCREENING; SEROLOGY; TOXOPLASMOSIS;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; COHORT STUDIES; COMPARATIVE STUDY; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMAN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INCIDENCE; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; TOXOPLASMOSIS;

EID: 0026553955     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549209048407     Document Type: Article

References (41)

1. What can be done to prevent congenital toxoplasmosis?
2. Congenital toxoplasmosis: marginal comment
3. Screening for toxoplasma in pregnancy
4. Antenatal screening for toxoplasmosis in the UK
5. Congenital toxoplasmosis. A prospective study of the offspring of 542 women who acquired toxoplasmosis during pregnancy. Pathophysiology of congenital disease
6. Development of adverse sequelae in children born with subclinical congenital toxoplasma infection
7. Perinatal infections
8. Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease
9. Toxoplasmosis
10. Toxoplasmosis Symposium on parasitic infections
11. Konnatale Toxoplasmose mit verzögerter Immunantwort des Kindes
12. Immunoserology in infectious diseases
13. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis
14. Prenatal diagnosis of congenital toxoplasmosis
15. Early prenatal diagnosis of congenital toxoplasmosis using amniotic fluid samples and tissue culture
16. Recent primary toxoplasma infection indicated by a low avidity of specific IgG
17. Recent rubella virus infection indicated by a low avidity of specific IgG
18. Potential role of IgG avidity for diagnosing toxoplasmosis
19. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by the polymerasc chain reaction
20. Congenital toxoplasmosis and TORCH
21. Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection
22. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
23. Protein and nucleic acid blotting and immunobiochemical detection
24. Electrophorctic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications
25. Toxoplasmosis needs evaluation. An overview and proposals
26. The diagnosis and treatment of toxoplasmosis
27. Role of serology in the diagnosis of toxoplasmic lymphadenopathy
28. Interlaboratory evaluation of indirect enzyme-linked immunosorbent assay, antibody capture enzyme-linked immunosorbent assay, and immunoblotting for detection of immunoglobulin M antibodies to Toxoplasma gondii
29. Infections in pregnancy
30. Epidemiology of toxoplasmosis among pregnant women in the Paris area
31. Human toxoplasmosis and cat contacts in Costa Rica
32. Incidence of toxoplasmosis in pregnant women in the city of Malmö, Sweden
33. The prevalence of toxoplasma antibodies among 11736 pregnant women in Norway
34. Screening for toxoplasmosis in pregnancy
35. A prospective study of acquired toxoplasmosis among 8043 pregnant women in the Oslo area
36. Congenital toxoplasmosis; a prospective survey in the West Scotland
37. Diagnosis of congenital toxoplasmosis in Scotland
38. What is known about the prevention of congenital toxoplasmosis?
39. Preventing congenital toxoplasmosis
40. Results of 20-year follow-up of congenital toxoplasmosis